| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiora Pharmaceuticals Inc (KPRX) has 0 insiders with recent SEC Form 4 filings, including 75 buys and 6 sells. KPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2019 | Mann Brenda | VP Of Research &Development | Sell | 19,049 | $0.24 | $4,503.18 | -3.4% | |
| Jul 15, 2019 | Romano Sarah81 | Chief Financial Officer | Sell | 19,750 | $0.24 | $4,668.90 | -2.4% | |
| Mar 29, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 549,647 | $0.32 | $175,216.45 | +0.5% | |
| Dec 11, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 100,353 | $0.40 | $40,316.08 | - | |
| Nov 16, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 360,000 | $0.45 | $161,395.09 | +0.2% | |
| May 29, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 58,275 | $0.57 | $33,432.59 | - | |
| May 18, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 1,725 | $0.56 | $959.10 | - | |
| May 14, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 15,758 | $0.53 | $8,417.50 | - | |
| May 11, 2018 | Armistice Capital, LLC56 | 10% Owner | Buy | 177,012 | $0.51 | $90,991.63 | +0.1% | |
| May 8, 2018 | Armistice Capital, LLC56 | 10% Owner | Buy | 137,230 | $0.46 | $63,472.26 | - |